World Health Organization Sounds Alert Over Acute Scarcity of Weight-Loss Injections
Less than 10% of people who could benefit from weight-loss injections like Wegovy are able to get them, caution the World Health Organization as it publishes its first advice on the drugs.
Considering more than one billion people worldwide currently obese, it is urging broader and more equitable availability to this class of drugs.
Per projections, in excess of 2,000,000,000 are projected to be obese by 2030 if no action is taken.
"The latest guidance affirms that obesity is a chronic disease that can be addressed with comprehensive and ongoing treatment," said WHO director-general Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and supply-chain constraints are major obstacles to broad availability to the treatments that can assist patients in reducing considerable weight, explains the body.
Skinny Jab Shortage
Even in the present most favorable case, the supply of GLP-1 therapies might only reach about 100 million people – under 10% of eligible patients, as stated by the health organization.
The guideline urges nations and manufacturers to increase access, through strategies like voluntary licensing.
Exclusive production rights on the active ingredient – the primary component of a leading brand – is scheduled to end in a number of nations in 2026.
How Obesity Jabs Function
These medications mimick a body's own hormone to delay gastric emptying, curb appetite and boost satiety so people reduce food intake.
Patients typically start to lose weight after several weeks of starting on the regular doses.
Studies indicates patients may see weight return after a year of discontinuing the treatment, as their usual hunger return.
Being carrying excess weight elevates your chance for experiencing health problems, such as diabetes, cardiovascular issues, brain attack, and certain cancers.
Excess weight affects individuals in every country and was associated with 3.7 million deaths worldwide in 2024, according to the health agency.